Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Urology
|
November 8, 2025
Short- and Long-Term Functional Outcomes in a Large Cohort of Partial Nephrectomy Patients Managed with Prolonged Ischemia
Akira Kazama, Kieran Lewis, Carlos Munoz-Lopez, et al.
BJU International
|
July 3, 2025
Degree of contrast enhancement improves prediction of new baseline glomerular filtration rate following radical nephrectomy
Jayant Siva, Anne Wong, Kieran Lewis, et al.
Urology Practice
|
May 5, 2025
A Split Renal Function-Based Approach for Predicting New Baseline Glomerular Filtration Rate After Radical Nephroureterectomy
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urology Practice
|
January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal Masses
Kieran Lewis, Jason M Scovell, Eran N Maina, et al.
Minerva Urology and Nephrology
|
September 2, 2025
Parenchymal volume and functional recovery after clamped partial nephrectomy: potential discrepancies
Kieran Lewis, Akira Kazama, Carlos Munoz Lopez, et al.
The Journal of Biological Chemistry
|
December 29, 2011
Engineering upper hinge improves stability and effector function of a human IgG1
Boxu Yan, Daniel Boyd, Timothy Kaschak, et al.
Immunity
|
July 14, 2021
Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
Shilpa Keerthivasan, Yasin Şenbabaoğlu, Nadia Martinez-Martin, et al.
BJUI Compass
|
March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal masses
Akira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Science Translational Medicine
|
December 17, 2011
Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1
Ai-Luen Wu, Ganesh Kolumam, Scott Stawicki, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Urology
|
November 8, 2025
Short- and Long-Term Functional Outcomes in a Large Cohort of Partial Nephrectomy Patients Managed with Prolonged Ischemia
Akira Kazama, Kieran Lewis, Carlos Munoz-Lopez, et al.
BJU International
|
July 3, 2025
Degree of contrast enhancement improves prediction of new baseline glomerular filtration rate following radical nephrectomy
Jayant Siva, Anne Wong, Kieran Lewis, et al.
Urology Practice
|
May 5, 2025
A Split Renal Function-Based Approach for Predicting New Baseline Glomerular Filtration Rate After Radical Nephroureterectomy
Kieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Urology Practice
|
January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal Masses
Kieran Lewis, Jason M Scovell, Eran N Maina, et al.
Minerva Urology and Nephrology
|
September 2, 2025
Parenchymal volume and functional recovery after clamped partial nephrectomy: potential discrepancies
Kieran Lewis, Akira Kazama, Carlos Munoz Lopez, et al.
The Journal of Biological Chemistry
|
December 29, 2011
Engineering upper hinge improves stability and effector function of a human IgG1
Boxu Yan, Daniel Boyd, Timothy Kaschak, et al.
Immunity
|
July 14, 2021
Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
Shilpa Keerthivasan, Yasin Şenbabaoğlu, Nadia Martinez-Martin, et al.
BJUI Compass
|
March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal masses
Akira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Science Translational Medicine
|
December 17, 2011
Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1
Ai-Luen Wu, Ganesh Kolumam, Scott Stawicki, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Page
of 6